|
Index of reports
> Cases resulting in death (7)
Below is the selection of adverse event reports related to Zantac (Ranitidine) that includes cases resulting in death.
Adverse event in male receiving Zantac (Ranitidine)
Reported by a physician from Japan on 2007-10-30
Patient: male
Adverse reactions / side effects: Interstitial Lung Disease, Respiratory Failure, Lung Abscess
Adverse event resulted in: death
Suspect drug(s):
Finibax
Finibax
Indication: Lung Abscess
Norvasc
Administration route: Oral
Indication: Drug USE FOR Unknown Indication
Itraconazole
Administration route: Oral
Indication: Drug USE FOR Unknown Indication
Zantac
Administration route: Oral
Indication: Drug USE FOR Unknown Indication
Ferromia
Administration route: Oral
Indication: Drug USE FOR Unknown Indication
Erythrocin
Administration route: Oral
Indication: Drug USE FOR Unknown Indication
Biofermin R
Administration route: Oral
Indication: Drug USE FOR Unknown Indication
Sucralfate
Administration route: Oral
Indication: Drug USE FOR Unknown Indication
Slow-K
Administration route: Oral
Indication: Drug USE FOR Unknown Indication
Mucosta
Administration route: Oral
Indication: Drug USE FOR Unknown Indication
Juzen-Taiho-TO
Administration route: Oral
Indication: Drug USE FOR Unknown Indication
Other drugs received by patient: Cravit
Adverse event in male receiving Zantac (Ranitidine)
Reported by a physician from Japan on 2007-10-19
Patient: male
Adverse reactions / side effects: Interstitial Lung Disease, Lung Abscess
Adverse event resulted in: death, life threatening event
Suspect drug(s):
Finibax
Finibax
Indication: Lung Abscess
Norvasc
Administration route: Oral
Indication: Drug USE FOR Unknown Indication
Itraconazole
Administration route: Oral
Indication: Drug USE FOR Unknown Indication
Zantac
Administration route: Oral
Indication: Drug USE FOR Unknown Indication
Ferromia
Administration route: Oral
Indication: Drug USE FOR Unknown Indication
Erythrocin Lactobionate
Administration route: Oral
Indication: Drug USE FOR Unknown Indication
Biofermin R
Administration route: Oral
Indication: Drug USE FOR Unknown Indication
Sucralfate
Administration route: Oral
Indication: Drug USE FOR Unknown Indication
Slow-K
Administration route: Oral
Indication: Drug USE FOR Unknown Indication
Mucosta
Administration route: Oral
Indication: Drug USE FOR Unknown Indication
Juzen-Taiho-TO
Administration route: Oral
Indication: Drug USE FOR Unknown Indication
Other drugs received by patient: Levofloxacin
Adverse event in 58 year old female receiving Zantac (Ranitidine)
Reported by a consumer/non-health professional from France on 2007-04-20
Patient: 58 year old female, weighing 95.0 kg (209.0 pounds)
Adverse reactions / side effects: Abdominal Pain, Hepatic Necrosis, Mydriasis, Anaphylactic Shock, Livedo Reticularis, Erythema, Paraesthesia, Loss of Consciousness, Syncope, Renal Impairment, Cardiac Arrest, Anuria
Adverse event resulted in: death, hospitalization
Suspect drug(s):
Zantac
Dosage: 25mg single dose
Start date: 2007-03-09
End date: 2007-03-09
Zantac
Dosage: 25mg single dose
Start date: 2007-02-09
End date: 2007-02-09
Polaramine
Dosage: 2.5mg single dose
Start date: 2007-03-09
End date: 2007-03-09
Other drugs received by patient: Polaramine; Taxol; Herceptin; Carboplatin; Solu-Medrol
Adverse event in 57 year old female receiving Zantac (Ranitidine)
Reported by a individual with unspecified qualification from Germany on 2007-04-10
Patient: 57 year old female
Adverse reactions / side effects: Myoclonus, Overdose, Bradypnoea, Miosis, Drug Interaction, Respiratory Depression, Hyperhidrosis, Somnolence
Adverse event resulted in: death, life threatening event
Suspect drug(s):
Zantac
Dosage: unk / unknown / injection
Morphine
Dosage: unk / unknown / intravenous
Other drugs received by patient: Paclitaxel; ME-Prednisolone NA Succ.; Dexchlorpheniram.maleate; Alprazolam; Amitriptyline HCL; Gabapentin; Esomeprazole Magnesium; Ondansetron HCL; Metoclopramide HCL
Adverse event in 56 year old female receiving Zantac (Ranitidine)
Reported by a physician from Cameroon on 2007-03-26
Patient: 56 year old female
Adverse reactions / side effects: Chills, Delirium, Asthenia, Convulsion
Adverse event resulted in: death
Suspect drug(s):
Zantac (Ranitidine)
Other drugs received by patient: Metronidazole; Acetaminophen; Cephalosporin
Adverse event in 33 year old female receiving Zantac (Ranitidine)
Reported by a consumer/non-health professional from Sweden on 2007-02-02
Patient: 33 year old female
Adverse reactions / side effects: Vomiting, Adrenocortical Insufficiency Acute, Diarrhoea, Adrenal Cortical Insufficiency, Gastroenteritis, Blood Potassium Increased, Sudden Death, Cardiac Arrest
Adverse event resulted in: death
Suspect drug(s):
Betapred
Administration route: Oral
Indication: Iritis
Zantac
Dosage: 600mg per day
Administration route: Oral
Indication: Gastritis
Start date: 2005-11-07
Reductil
Dosage: 10mg per day
Administration route: Oral
Indication: Obesity
Start date: 2005-12-13
Adverse event in 33 year old female receiving Zantac (Ranitidine)
Reported by a consumer/non-health professional from Sweden on 2007-01-29
Patient: 33 year old female
Adverse reactions / side effects: Adrenal Cortical Insufficiency, Sudden Death
Adverse event resulted in: death
Suspect drug(s):
Betapred
Dosage: 2.5mg per day
Administration route: Oral
Indication: Iritis
Zantac
Dosage: 600mg per day
Administration route: Oral
Indication: Gastritis
Start date: 2005-11-07
Reductil
Dosage: 10mg per day
Administration route: Oral
Indication: Obesity
Start date: 2005-12-13
|
